• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Shorts aren't shying away from the cannabis industry even after a series of squeezes.
By KEVIN CURRAN Nov 13, 2018 | 11:22 AM EST
Stocks quotes in this article: CRON, CGC, ACBFF, GWPRF, FB, PYPL, TLRY, TGODF

Shares of Canadian cannabis leader Tilray Inc.  (TLRY) are dipping on Tuesday, which might entice short-sellers awaiting a big correction in the stock.

Tilray's volatile nature and the disconnect found in its nearly $11 billion market cap in relation to less than $10 million in sales in the second quarter has kept shorts steady. The pessimistic onlookers are awaiting a price drop even after a September surge that famously squeezed so many shorts.

Maybe the most famous short-seller among the bunch is Citron Research's Andrew Left, who has called British Columbia-based Tilray's intermittent surges in recent months "retail investors gone mad."

Left said he remains confident in his position at the Reuters Global Investment 2019 Outlook Summit in New York on Monday, noting that the potential for U.S. legalization that is bolstering confidence could actually be a death knell.

"When U.S. LPs go public in the next few years it will make these Canadian companies laughable," he said. "The cannabis trade is a perfect trade because the cannabis trade is a non-branded, no-moat mega-trend."

S3 Partners, a short interest analytics firm, noted that Left is far from alone in his criticism of Tilray and cannabis stocks more generally.

"With the cannabis sector rallying in 2018, short-sellers have added almost $1.4 billion of exposure since mid-year, hoping for a reversal in what they believe to be an over-heated and over-valued sector," managing director Ihor Dusaniwsky wrote in a report on Nov. 8. "Short interest is now $3.35 billion in the 141 securities we track in our cannabis basket."

He noted that over 90% of this short interest is concentrated in just 10 securities, with much of it targeted at Tilray.

Price Prohibitive

The problem for short-sellers is that the borrowing cost to continue shorting the stocks is exorbitant.

"While short-selling and timing the cannabis market may be a profitable endeavor, there is a steep cost to enter the trade," Dusaniwsky noted. "Several of the most shorted cannabis stocks have very high borrow costs with TLRY at 38% fee, Cronos  (CRON) at 42% fee and Green Organic Dutchman (TGODF) at a 50% fee."

A data report shows that shorts are currently losing $1.3 million per day on stock borrow financing to keep up their bearish bets.

Canopy Growth Corp.  (CGC) , Stocks Under $10 holding Aurora Cannabis (ACBFF) , Tilray, GW Pharmaceuticals (GWPRF) , and Cronos Group are currently the five most shorted stocks in the market, in that order.

January Judgment Day

Even still, the bearish bettors are not backing off and are instead anticipating a jolt downward in January.

Jan. 15 is a pivotal date for the cannabis company, as it marks the end of Tilray's post-IPO lockup period. The lifting of the restriction would allow Privateer Holdings, the company's largest shareholder, to cash out on its 76.7% stake in the company.

The Seattle-based private equity firm is backed by PayPal Holdings  (PYPL) founder and Facebook (FB) investor Peter Thiel, and counts Tilray founder and CEO Brendan Kennedy as an executive.

Any significant drop-off in the major shareholder's stake would dilute shares and likely tempering the company's rapid growth profile.

"What happens the day the lockup expires and the float doubles? What happens to the stock then?" Andrew Left said at the Reuters conference.

The options market heading into next year is following Left's lead.

Jan. 18-dated $60 puts currently command the highest open interest for next year's available options.

More immediately, the options market is pricing in heavy volatility for Tilray on its earnings Tuesday evening. The market is pricing in a 27.3% post-earnings move for the stock, according to Schaeffers Research.

Such a move could vindicate or obliterate the bevy of short-sellers following the stock.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

Action Alerts PLUS, which Jim Cramer manages as a charitable trust, is long PYPL and FB.

TAGS: Earnings | Investing | Stocks | Pharmaceuticals | Cannabis

More from Stocks

A Quiet Conclusion to a Dramatic and Contentious Issue

James "Rev Shark" DePorre
Dec 13, 2019 4:24 PM EST

This market has such a positive brew that has to make you at least a little apprehensive.

Put These 2 Stocks on Your Radar for the Week Ahead

Timothy Collins
Dec 13, 2019 1:00 PM EST

While both have 'Technologies' in their name, they don't share the same space.

My Trade Idea for Oracle

Stephen Guilfoyle
Dec 13, 2019 12:30 PM EST

ORCL is competing for the business to business cloud, obviously a tough space.

When You're Wrong, You're Wrong

Guy Ortmann
Dec 13, 2019 12:08 PM EST

We are upgrading our near-term market outlook.

Ignore Politics! Stocks Are a Terrific Investment, and Reinvest Your Dividends

Jim Collins
Dec 13, 2019 12:00 PM EST

Anyone who thinks that the markets won't exist in their current form in 10, 20 or 50 years just has never read any economic history.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:10 AM EST BOB LANG

    Banking a Big Winner in SRPT, Rolling Up

    Nov. 20 here on the CC, I mentioned buying some Ma...
  • 10:36 AM EST GARY BERMAN

    Fibocall: How High Can Crude Go?

    On crude: I am looking for higher, but please b...
  • 08:20 AM EST BOB LANG

    Webinar Time - Talkin' Calendars, Butterflys

    join me later today after the market close as we t...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login